Assessment of bacille Calmette-Guérin vaccine reaction in HIV-exposed Thai infants
We evaluated local reactions at 1, 2, and 4 months of age to bacille Calmette-Guérin vaccine given at birth to 1058 infants who were exposed to human immunodeficiency virus (HIV). No scar was discernible in 12 (12.4%) of 97 HIV-infected infants and 20 (2.1%) of 961 uninfected infants (relative risk, 5.9; 95% confidence interval, 3.0-11.8). This difference may reflect poorer immunogenicity in HIV-infected infants.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2007 |
---|---|
Erschienen: |
2007 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 45(2007), 8 vom: 15. Okt., Seite 1016-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chokephaibulkit, Kulkanya [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 04.10.2007 Date Revised 20.09.2007 published: Print-Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM173863388 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM173863388 | ||
003 | DE-627 | ||
005 | 20231223134655.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2007 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0580.xml |
035 | |a (DE-627)NLM173863388 | ||
035 | |a (NLM)17879918 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chokephaibulkit, Kulkanya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessment of bacille Calmette-Guérin vaccine reaction in HIV-exposed Thai infants |
264 | 1 | |c 2007 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.10.2007 | ||
500 | |a Date Revised 20.09.2007 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a We evaluated local reactions at 1, 2, and 4 months of age to bacille Calmette-Guérin vaccine given at birth to 1058 infants who were exposed to human immunodeficiency virus (HIV). No scar was discernible in 12 (12.4%) of 97 HIV-infected infants and 20 (2.1%) of 961 uninfected infants (relative risk, 5.9; 95% confidence interval, 3.0-11.8). This difference may reflect poorer immunogenicity in HIV-infected infants | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Chotpitayasunondh, Tawee |e verfasserin |4 aut | |
700 | 1 | |a Vanprapar, Nirun |e verfasserin |4 aut | |
700 | 1 | |a Waranawat, Naris |e verfasserin |4 aut | |
700 | 1 | |a Mock, Philip A |e verfasserin |4 aut | |
700 | 1 | |a McConnell, Michelle S |e verfasserin |4 aut | |
700 | 1 | |a Jetswang, Bongkoch |e verfasserin |4 aut | |
700 | 1 | |a Neeyapun, Kanchana |e verfasserin |4 aut | |
700 | 1 | |a Tappero, Jordan W |e verfasserin |4 aut | |
700 | 1 | |a Culnane, Mary |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 45(2007), 8 vom: 15. Okt., Seite 1016-8 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2007 |g number:8 |g day:15 |g month:10 |g pages:1016-8 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 45 |j 2007 |e 8 |b 15 |c 10 |h 1016-8 |